| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/25/2009 | US20090162321 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| 06/25/2009 | CA2707235A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 06/24/2009 | CN101463345A Virus propagation promotor and use thereof |
| 06/24/2009 | CN100503817C Preparation method of recombinant baculoviral for constructing fowl vaccine |
| 06/24/2009 | CN100503816C Recombinant gene engineered strain of aujeszkys disease-porcine reproductive and respirator syndrome virus, and its uses |
| 06/23/2009 | US7550647 Transfected shrimp as production systems for therapeutic proteins |
| 06/23/2009 | US7550284 Production of vaccines |
| 06/23/2009 | US7550283 Bacteriophage for lysis of Methylobacterium and compositions and uses thereof |
| 06/23/2009 | US7550148 Contacting the target cell with a recombinant HSV particle comprising an altered gD forming a fusion with a peptide ligand to a receptor specific to the cell wherein the altered gD exhibits reduced binding to at least one of the cellular receptors of wild type gD; cell imaging; gene therapy; kits |
| 06/23/2009 | US7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/23/2009 | CA2337494C Herpes virus vectors for dendritic cells |
| 06/23/2009 | CA2250078C Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 06/23/2009 | CA2163456C New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 06/18/2009 | WO2009076668A2 Bacteriophage preparations and method of use thereof |
| 06/18/2009 | WO2009075884A1 Novel e. coli bacteriophages and uses thereof |
| 06/18/2009 | WO2009014878A3 Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| 06/18/2009 | WO2004070002A3 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/18/2009 | US20090158460 Plant Diacylglycerol Acyltransferases |
| 06/18/2009 | US20090155884 amino acid sequences covalent attached to retroviruses or to leukemia virus transmembrane glycoproteins; phage display libraries; drug targets |
| 06/18/2009 | US20090155883 Scientifically Modulated And Reprogrammed Treatment (SMART) Virus Technology Intended to Neutralize the Human Immunodeficiency Virus |
| 06/18/2009 | US20090155854 METHOD FOR AMPLIFYING A FLAVIVIRUS cDNA IN A PROKARYOTIC CELL |
| 06/18/2009 | US20090155810 Methods for producing members of specific binding pairs |
| 06/18/2009 | US20090155771 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same |
| 06/18/2009 | US20090155349 Methods of treating influenza viral infections |
| 06/18/2009 | US20090155329 dipping or soaking the food product(s) in a solution containing a concentration of the bacteriophage formulation sufficiently high to inhibit the growth of esherichia coli strains, or adding, injecting or inserting the bacteriophage formulation into the food product; strong lytic activity |
| 06/18/2009 | US20090155312 Viral variants detection and application |
| 06/18/2009 | US20090155310 Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope |
| 06/18/2009 | US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases |
| 06/18/2009 | US20090155301 Pseudoinfectious flavivirus and uses thereof |
| 06/18/2009 | US20090155287 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 06/18/2009 | US20090155250 Monoclonal antibodies against orthopoxviruses |
| 06/18/2009 | US20090155217 Novel E. coli O157:H7 Bacteriophage and Uses Thereof |
| 06/18/2009 | US20090155215 Engineered enzymatically active bacteriophage and methods for dispersing biofilms |
| 06/17/2009 | EP2071024A1 Peptides of human prostatic acid phosphatase enhancing viral infectivity |
| 06/17/2009 | EP2069484A1 Influenza b viruses having alterations in the hemaglutinin polypeptide |
| 06/17/2009 | EP2069483A2 Recombinant rhinovirus vectors |
| 06/17/2009 | EP2069482A2 Influencing viral lipid constituents |
| 06/17/2009 | EP2069480A2 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 06/17/2009 | EP1358319B1 Live influenza vaccine and method of manufacture |
| 06/17/2009 | EP0968277B1 Filtration method for separating viruses |
| 06/17/2009 | CN101457215A Recombinant porcine pseudorabies virus-porcine propagate and breath complex virus-porcine circovirus genetic engineering strain and application |
| 06/17/2009 | CN100500836C Method for culturing HCV virus in vitro |
| 06/17/2009 | CN100500827C Method of culturing and propagating poliomyelitis virus with human embryo lung diploid |
| 06/17/2009 | CN100500222C Cancer targeted double gene-virus, its structure method and application thereof |
| 06/16/2009 | US7547773 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer |
| 06/16/2009 | US7547442 Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
| 06/16/2009 | US7547395 Formed by polymerizing, under freezing, aqueous solution of acrylamide and N,N-methylene-bis-acrylamide, in presence of initiator system, thawing, transamidating with ethylenediamine, treating with divinylsulfone and iminodiacetic acid, then loading copper ions; chromatographic/electrical separations |
| 06/11/2009 | WO2009073104A2 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 06/11/2009 | WO2009072147A1 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof |
| 06/11/2009 | WO2009054996A3 Systems and methods for viral therapy |
| 06/11/2009 | WO2009050390A3 Method for producing flu virus |
| 06/11/2009 | WO2008076915A8 Treatment of pigs with pcv2 antigen |
| 06/11/2009 | WO2005112567A9 Vaginal microbicide |
| 06/11/2009 | US20090151012 Animal Model Having a Chimeric Human Liver and Susceptible to Human Hepatitis C Virus Infection |
| 06/11/2009 | US20090149409 Tetracycline-Regulated Adeno-Associated Viral (AAV) Vectors for Gene Delivery to the Nervous System |
| 06/11/2009 | US20090149405 Virus-like particle containing a Dengue virus recombinant replicon |
| 06/11/2009 | US20090149349 Recombinant adenoviruses preparation and adenovirus banks |
| 06/11/2009 | US20090149331 Methods and compositions for polypeptide engineering |
| 06/11/2009 | US20090148832 Compositions and Methods for Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | EP1613724A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/11/2009 | CA2706258A1 Simian subfamily e adenoviruses sadv-39, -25.2, -26, -30, -37, and -38 and uses thereof |
| 06/11/2009 | CA2706257A1 Simian subfamily b adenovirus sadv-28, -27, -29, -32, -33 and -35 and uses thereof |
| 06/10/2009 | EP2067856A1 Method of proliferating hepatitis virus, hollow fiber for culturing hepatitis virus-infected cells and utilization of the same |
| 06/10/2009 | EP2066418A1 Separation matrix for viral purification |
| 06/10/2009 | EP2066347A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases |
| 06/10/2009 | EP1685254B1 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/10/2009 | CN101454442A Construction of chimera PRRSV, compositions and vaccine preparations |
| 06/10/2009 | CN100497605C Anti cancer targeted regulatory gene-virus and construction method thereof |
| 06/10/2009 | CN100497604C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 06/09/2009 | US7544791 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544775 Comprises successively in 5'-3' direction a nucleotide sequence encoding the dipeptide Asp-Pro and a nucleotide sequence encoding a toxic protein; for overexpressing recombinant proteins with or without fusion to a soluble protein |
| 06/09/2009 | US7544467 Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV) |
| 06/09/2009 | US7544362 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 06/04/2009 | WO2009070700A1 Recombinant bcg tuberculosis vaccine for eliciting immune responses to mycobacterium tuberculosis |
| 06/04/2009 | WO2009068870A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | WO2009068753A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 06/04/2009 | WO2009009670A4 Apparatus and method for harvesting biologics from eggs |
| 06/04/2009 | WO2009006420A3 Vaccine production for pathogenic bird viral diseases |
| 06/04/2009 | WO2006099360A3 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 06/04/2009 | US20090143289 Orthopoxvirus vectors, genes and products thereof |
| 06/04/2009 | US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 06/04/2009 | US20090142823 Attenuated rna virus and applications thereof |
| 06/04/2009 | US20090142371 Hiv recombinant vaccine |
| 06/04/2009 | CA2706603A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | CA2706415A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2065393A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 06/03/2009 | EP2064229A2 Oncolytic rhabdovirus |
| 06/03/2009 | CN101444539A Use of strains of the parapox ovis virus against organ fibrosis |
| 06/03/2009 | CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/02/2009 | US7541179 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 06/02/2009 | CA2339089C Cold-adapted equine influenza viruses |
| 05/28/2009 | WO2009066802A1 Biological membrane-intrinsic virus-like particle, and method for production thereof |
| 05/28/2009 | WO2009066247A1 A process for preparing attenuated viral strains |
| 05/28/2009 | WO2009065573A1 Bacteriophages and coating material for surfaces |
| 05/28/2009 | WO2009036933A9 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 05/28/2009 | US20090138977 Pancreatic cancer targets and uses thereof |
| 05/28/2009 | US20090137424 Selective Posttranslational Modification of Phage-Displayed Polypeptides |